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Abstract
Introduction: Patients with acute stroke are at high risk for infection. These infections are associated with unfavour-
able outcome after stroke. A prediction rule can identify the patients at the highest risk for strategies to prevent
infection. We aim to develop a prediction rule for post-stroke pneumonia and other infections in patients with
acute stroke.
Patients and methods: We used data from the Preventive Antibiotics in Stroke Study, a multicentre randomised trial
comparing preventive ceftriaxone vs. standard stroke care in patients with acute stroke. Possible predictors for post-
stroke pneumonia or infection were selected from the literature. Backward elimination logistic regression analysis was
used to construct prediction rules for pneumonia or infection. Internal validation was performed and a risk chart was
constructed. We adjusted for preventive antibiotic use.
Results: Pneumonia was diagnosed in 159 of the 2538 included patients, and infection in 348. Pneumonia was predicted
by higher age, male sex, pre-stroke disability, medical history of chronic obstructive pulmonary disease, more severe
stroke, dysphagia and intracerebral haemorrhage (rather than ischaemic stroke). Infections were predicted by higher
age, male sex, history of diabetes, chronic obstructive pulmonary disease, more severe stroke, dysphagia, use of bladder
catheter, preventive antibiotic use and intracerebral haemorrhage. With the prediction rule developed, risks for
pneumonia ranged from 0.4% to 56.2% and from 1.8% to 88.0% for infection. Discrimination of the score was good
(C-statistic, 0.84; 95% CI: 0.81–0.87 and 0.82; 95% CI: 0.79–0.84 for pneumonia and infection).
Conclusions: The Preventive Antibiotics in Stroke Study pneumonia and infection rule identify patients at the highest
risk for post-stroke pneumonia or infection and may be used for future studies and novel therapies, after confirmation in
an external population.
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Introduction
Post-stroke infections occur in 30% of the patients with
acute stroke and have a strong relation with unfavour-
able outcome.1–3 In two recent large randomised trials,
preventive antibiotic therapy did not improve function-
al outcome in relatively unselected patients with
acute stroke.4,5 New approaches are needed to prevent
infection and thereby improve outcome in acute
stroke patients. One option would be to prevent
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infection only in those with high risk of developing
these infections.
Risk scores aiming to predict pneumonia in patients
with acute stroke have previously been developed.
These were mostly derived from retrospective cohort
studies or large stroke registries and often were not
specifically designed to predict post-stroke infections
in general.6–11 In contrast to many models aimed at
predicting post-stroke pneumonia, only one study in
568 stroke patients aimed at predicting post-stroke
infection in general. The model developed in this
study was neither internally nor externally validated.
Predictors for pneumonia from these studies were
higher age, sex, more severe stroke, history of conges-
tive heart failure, history of pneumonia or chronic
obstructive pulmonary disease (COPD), current smok-
ing, alcoholism, prestroke dependence, reduced level of
consciousness, intracerebral haemorrhage (rather than
ischaemic stroke), higher systolic arterial blood pres-
sure, higher blood glucose, higher white blood cell
(WBC) count and infratentorial location, intraventric-
ular extension and volume of the haematoma. For any
infection, higher age, diabetes and more severe stroke
were predictors.
Aims
The current study aimed to construct a prediction rule
both for pneumonia and for any post-stroke infection
in patients with acute ischaemic stroke or intracerebral
haemorrhage, with data from the ‘Preventive
Antibiotics in Stroke Study’ (PASS).
Methods
Patients and definitions of outcome variables
Data were used from PASS, a multicentre, prospective,
randomised, open-label, clinical trial with blinded end-
point assessment (PROBE), including 2550 patients in
the acute phase (<24 h) of ischaemic stroke or intrace-
rebral haemorrhage. Patients with signs of an infection
at study inclusion were excluded. In this trial, preven-
tive treatment with intravenous ceftriaxone during four
days in addition to standard stroke care was compared
with standard stroke care alone. Ethics approval was
obtained from the local institutional review board and
all patients or their legal representatives provided writ-
ten informed consent. Baseline characteristics and
outcome parameters were prospectively collected.
Dysphagia was assessed by performing a swallowing
test according to national guidelines.12 We assessed
for each patient whether the swallowing test was per-
formed, the result of the test or the reason why it was
not performed (good recovery, reduced consciousness
or other reasons). A patient was considered dysphagic
in case of an abnormal swallowing function on the test.
A patient was considered not dysphagic in case of a
normal swallowing function on the test, or when the
test was not performed because of good recovery.
When the test was not performed due to lowered con-
sciousness or other reasons, dysphagic status was con-
sidered unavailable.
Definition of post-stroke infections
In the PASS, post-stroke infections were categorised as
diagnosed by the clinician, and as judged by an inde-
pendent adjudication committee blinded for treatment
allocation with modified Centres for Disease Control
and Prevention criteria, as described in the study pro-
tocol.5,13 In the current analyses, the occurrence of
pneumonia or infection as assessed by the clinician
during admission was used.
Selection of candidate predictors
Previously described risk factors for post-stroke pneu-
monia and infection were identified by literature search
(search strategy see Supplemental Appendix). To be
considered as candidate predictors, risk factors had to
be frequently described in literature and had to be col-
lected in the PASS dataset. The maximum number of
candidate predictors should range between the num-
bers of pneumonia or infection divided by 10–15
according to the events-per-variable rule.14 For exam-
ple, if the maximum number of candidate predictors
was 10, we chose the 10 most frequently reported risk
factors from literature. Each factor had to be known
at admission, since the aim of the prediction rule is
to assess infection risk early in clinical course.
Dysphagia assessment was performed at admission by
a trained nurse before any intake by a water swallowing
test according to the Dutch Stroke Guideline.12 Since
pneumonia is a subcategory of infection, predictors of
pneumonia were also used for prediction of infection.
We also considered treatment allocation as a candidate
predictor in both prediction rules.
Statistical analysis
All statistical analyses were performed in R version
3.2.4.15 We developed two prediction rules; one
for post-stroke pneumonia and one for post-
stroke infections.
For each variable, the proportion of missingness was
assessed. Missing data were imputed with single impu-
tation with 20 iterations using baseline and outcome
variables and the Mice Package.16 For continuous var-
iables, linearity was assessed by plotting the data and
examining the risk for each decile. Logistic regression
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analyses were performed to study the association
between candidate predictors as defined beforehand
(literature search) and the outcomes. Predictors for
pneumonia or infection were selected with backward
selection, using the Akaike Information Criterion as
stopping rule.14 Next, the performance of both predic-
tion rules was assessed by investigating the explained
variance, calibration curve and Hosmer–Lemeshow
test, and discrimination by c-statistic. Both prediction
rules were internally validated to prevent overfitting.
Regression coefficients were corrected for optimism by
a shrinkage factor obtained by bootstrapping (250 sam-
ples) including the full backward model. When treat-
ment allocation was selected as independent predictor,
we adjusted the intercept and presented the predicted
risks based on the standard care subset of the data.
We constructed prediction rules based on the regression
coefficients of the two models. For the performance of
this study, we adhered to the Tripod statement and com-
pleted the checklist (Supplemental Appendix).17
Results
Patients
Between July 2010 and March 2014, 2550 patients were
enrolled. Twelve patients withdrew consent immediate-
ly after randomisation, leaving 2538 patients available
for the analysis; 57% of patients were male, the median
NIHSS was 5 (IQR 3–9) and 26% of patients were
dysphagic (for all baseline characteristics see Table 1).
During admission, pneumonia was diagnosed in 159
and any infection in 348 patients (159 patients were
diagnosed with pneumonia, 173 patients with urinary
tract infections, 50 with other infections; see main
article PASS for specification of other infections5);
306 patients were diagnosed with a single infection,
and 48 with more than one infection: 29 patients had
two infections, 11 patients had 3 infections and
2 patients had 4 infections as diagnosed by the treating
physician.
Candidate predictors
The search strategy resulted in 2706 articles. After
screening titles, abstracts and full-text, 46 articles
were used for the extraction of risk factors for pneu-
monia and infection (see Supplemental Appendix). For
pneumonia, the most consistently reported risk factors
(>13 studies) were higher age, male sex, more severe
stroke and dysphagia. Other frequently reported risk
factors were decreased level of consciousness at admis-
sion, pre-stroke dependence, medical history of diabe-
tes, COPD, atrial fibrillation and intracerebral
haemorrhage. For infection, the most consistently
reported risk factors were higher age, male sex, more
severe stroke and a reduced consciousness on admis-
sion. Other relatively frequently reported risk factors
were pre-stroke dependence, medical history of diabe-
tes, previous stroke, atrial fibrillation, malignancy,
immune suppression (HIV, immunosuppressive medi-
cation, splenectomy) and urinary catheterisation. The
aforementioned risk factors were used as candidate
predictors. Age and stroke severity were the only con-
tinuous variables and had a linear association with
pneumonia and infection. The pre-stroke Modified
Rankin Scale Score (mRS) and GCS were a priori cat-
egorised in three groups (mRS: 0, 1–2, 3–5; GCS <13,
13–14 and 15).
Handling of missing data
There were no missing data for the candidate predic-
tors age, sex, intracerebral haemorrhage, pre-stroke
dependence, stroke severity and immune suppression.
For dysphagia, data were missing in 176 (6.9%)
patients, and in 199 patients (7.8%), the verbal score
of the GCS was missing (mostly because these patients
were aphasic). For all other candidate predictors, data
were missing in less than 0.3%.
Prediction rule
Post-stroke pneumonia was predicted by higher age,
male sex, pre-stroke disability, medical history of
COPD, more severe stroke, dysphagia and intracere-
bral haemorrhage. Post-stroke infections were pre-
dicted by higher age, male sex, medical history of
diabetes, COPD, more severe stroke, dysphagia, use
of bladder catheter, preventive antibiotic use and intra-
cerebral haemorrhage. Because of selection of preven-
tive antibiotic use as predictor for infection, the linear
predictor for infection was adjusted to the placebo pop-
ulation. The linear predictors for pneumonia and infec-
tion are shown in Table 4 of supplementary appendix,
together with the performance measures. After internal
validation by bootstrapping, the linear predictor for
pneumonia discriminated well between patients with
and those without pneumonia (C-statistic 0.83 95%CI
0.80–0.86). The study was well calibrated (Hosmer–
Lemeshow test p¼ 0.94). The linear predictor for infec-
tion discriminated well between patients with and those
without infection (c-statistic 0.82 95% CI 0.79–0.84)
and had a good calibration (Hosmer–Lemeshow test
p¼ 0.44). The calibration plots for pneumonia and
infection are shown in Figure 1.
Derivation of a prediction rule and chart
We derived the PASS pneumonia rule and the PASS
infection rule, 22 and 24 points scores respectively,
138 European Stroke Journal 3(2)
Table 1. Baseline characteristics preventive antibiotics in stroke study.
Ceftriaxone group
(n¼ 1268)
Control group
(n¼ 1270)
Age, years 73 (63–81) 74 (63–81)
Male sex 719 (57%) 725 (57%)
History
Atrial fibrillation/flutter 184/1265 (15%) 207/1269 (16%)
Stroke 406/1266 (32%) 421/1270 (33%)
Hypercholesterolaemia 332/1260 (26%) 333/1258 (27%)
Hypertension 694/1266 (55%) 706/1268 (56%)
Myocardial infarction 172/1266 (14%) 159/1270 (13%)
Cardiac valve diseasea 95/1265 (8%) 78/1270 (6%)
Peripheral vascular disease 91/1262 (7%) 99/1267 (8%)
Obstructive pulmonary disease 115/1267 (9%) 93/1266 (7%)
Diabetes mellitus 251/1268 (20%) 251/1270 (20%)
Alcoholism 58/1268 (5%) 64/1270 (5%)
Malignancy 112/1268 (9%) 122/1270 (10%)
Immunocompromisedb 53/1268 (4%) 31/1270 (2%)
Current smoker 319/1253 (26%) 301/1256 (24%)
Medication at baseline
Anticoagulants 142/1267 (11%) 141/1270 (11%)
Antiplatelet therapy 514/1267 (41%) 504/1269 (40%)
Statins 473/1266 (37%) 476/1270 (38%)
Angiotensin-converting enzyme inhibitors 347/1264 (28%) 297/1268 (23%)
b blockers 428/1266 (34%) 457/1267 (36%)
Proton pump inhibitors 327/1265 (26%) 328/1266 (26%)
Pre-stroke Modified Rankin Scale scorec 0 (0–1) 0 (0–1)
National Institutes of Health Stroke Scale scored 5 (3–9) 5 (3–9)
Dysphagia 307/1178 (26%) 316/1193 (27%)
Acute stroke treatment
Intravenous thrombolysis 437/1268 (35%) 399/1270 (31%)
Coagulant therapy 26/143 (18%) 19/125 (15%)
Discharge diagnosis
Ischaemic stroke 1058 (83%) 1067 (84%)
Transient ischaemic attack 44 (4%) 49 (4%)
Intracerebral haemorrhage 143 (11%) 126 (10%)
Other 23 (2%) 28 (2%)
Data are median (IQR) or n/N (%).
aCardiac valve disease was defined as cardiac valve insufficiency, stenosis, or replacement. bImmunocompromised was defined as
changed immune status, diabetes mellitus, alcoholism, malignancy or immunosuppressive medication.
cScores on the modified Rankin Scale range from 0 to 6, with 6 indicating death; modified Rankin Scale scores before onset of
stroke symptoms were assessed in 2538 patients (1268 in the ceftriaxone group and 1270 in the control group).
dScores on the National Institutes of Health Stroke Scale range from 0 to 30, with 30 indicating highest degree of stroke severity;
these scores were assessed in 2538 patients (1268 in the ceftriaxone group and 1270 in the standard treatment group).
Figure 1. Calibration plot for pneumonia and infection. Legend ideal: line drawn for the situation in which predicted probabilities
perfectly match the observed probabilities. Nonparametric: line displaying observed probabilities. Grouped observations: observed
probabilities for 10 groups of equal size.
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which were both subdivided in four categories
(Figure 2). Predicted risk for the lowest and highest
score on the prediction rule ranged from 0.4 to
56.2% for pneumonia and 1.8% to 88.0% for infec-
tion. In Figure 2, the observed risks in the PASS pop-
ulation are shown for each point on the PASS
pneumonia and infection rule. Discrimination of the
derived scores remained good (C-statistic 0.84 95%CI
0.81–0.87 and 0.82 95% CI 0.79–0.84 for pneumonia
and infection, respectively).
Discussion
Post-stroke infections were predicted by higher age,
male sex, history of diabetes, history of COPD, more
severe stroke, dysphagia, use of a bladder catheter and
Figure 2. Score on PASS prediction rule and predicted risks for pneumonia and infection.
PASS: preventive antibiotics in stroke study.
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intracerebral haemorrhage. Post-stroke pneumonia
was predicted by higher age, male sex, pre-stroke dis-
ability, history of COPD, more severe stroke, dyspha-
gia and intracerebral haemorrhage.
Our study is the first to develop and internally
validate a prediction score for post-stroke infection.
Post-stroke pneumonia is the most studied infection
because of the strongest association with mortality
Table 2. Models to predict pneumonia or infection in acute ischaemic stroke or intracerebral haemorrhage patients.
Author, year, name
Stroke
type Study design
No. of
patients in
derivation
group Predictors C-statistic Validation
Pneumonia
Kwon et al., 200610
The pneumonia score
I&H Cohort study 286 Age, sex NIHSS, dysphagia,
mechanical ventilation
NR None
Chumbler
et al., 20106
I&H Retrospective
cohort
926 Age, stroke severity,
dysphagia, history of
pneumonia, patient being
‘found down’ at symp-
tom onset
0.78 (D);
0.76 (V)
Internal
Hoffmann et al., 20127
A2DS2-score
I Registry 15,335 Age, sex, stroke severity,
dysphagia, atrial fibrillation
0.84 (D);
0.84 (V)
External
Ji et al., 20139
AIS-APS
I Registry 8820 Age, history of atrial fibrilla-
tion, congestive heart
failure, COPD, current
smoking, prestroke depen-
dence, dysphagia, NIHSS,
GCS, stroke subtype,
blood glucose
0.79 (D);
0.79 (V)
External
Ji et al., 20148
ICH-APS
H Registry 2998 Age, NIHSS, prestroke
dependence, GCS,
dysphagia, current smok-
ing, alcoholism, COPD,
infratentorial location of
ICH, intraventricular
extension, hemato-
ma volume.
0.75 (D);
0.76 (V)
Internal
Harms et al., 201318
Pantheris-score
I on ICU RCT 114 age, GCS, systolic arterial
blood pressure,
WBC count
0.85 (D);
0.88 (int. V)
Internal
Smith et al., 201511
ISAN-score
I&H Registry 11,551 Age, sex, NIHSS, prestroke
independence
0.79 (D);
0.78 (V)
External
Kumar et al, 201720
ACDD4-score
I&H Retrospective
cohort
1644 Age, congestive heart failure,
dysarthria, dysphagia
0.82 (D);
0.81 (V)
Internal
Westendorp
et al., 2017
PASS score
I&H RCT 2538 Age, sex, pre-stroke disability,
medical history of COPD,
stroke severity, dysphagia,
intracerebral haemorrhage
0.82 (IV) Internal
Infection
Friedant et al., 201521 I Retrospective
cohort
568 Age, diabetes, stroke severity NR None
Westendorp et al., 2017
PASS score
I&H RCT 2538 Age, male sex, diabetes,
medical history of COPD,
stroke severity, dysphagia,
bladder catheter, intrace-
rebral haemorrhage
0.84 (IV) Internal
I: ischaemic; H : haemorrhagic; WBC : white blood cell; COPD : chronic obstructive pulmonary disease; NIHSS: National Institutes of Health Stroke
Scale score; GCS : Glasgow coma scale; NR: not reported; D : derivation; V : validation; IV : internal validation.
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and unfavourable functional outcome. However, other
infections such as urinary tract infection, phlebitis,
gastro-intestinal infections, sepsis and infections with-
out determined focus can complicate and influence the
clinical course after stroke as well. Infections have been
shown to complicate the clinical course in 30%, while
pneumonia occurs in 10% of stroke patients.3 Because
infections are also associated with mortality and unfav-
ourable functional outcome, it seems necessary to aim
therapies not only at prevention of pneumonia, but at
preventing all infections.2,3 In PASS, preventive antibi-
otic therapy did not have an effect on functional out-
come in the overall population, but did reduce infection
rate. Whether preventive antibiotic therapy in a high-
risk subgroup does improve functional outcome
remains to be investigated. The PASS prediction rule
has the potential, after external validation, to identify
the patients at high risk of infections and could be an
important first step for selection of patients for future
trials or intensive monitoring for the development of an
infection during admission.
Previous models have been developed to predict
pneumonia after stroke (see Table 2 for overview of
all models). Four scores were also externally validated:
the A2DS2 and AIS-APS scores for ischaemic stroke,
the ICH-APS for intracerebral haemorrhage and the
ISAN-score for both ischaemic stroke and intracere-
bral haemorrhage.7–9,11 These four scores were devel-
oped from and mostly validated in large stroke
registries. The other available prediction models for
prediction of pneumonia after stroke were mostly
based on a smaller number of patients and often too
many predictors were included according to the events-
per-variable rule, which can lead to overfitting and
poorer performance of the model.6,10,14,18 The present
study adds to previous models because it was con-
structed from data from a large prospective rando-
mised trial in which infection and pneumonia were
predefined outcome parameters and might therefore
have been more rigorously assessed. Also, patients
with infection at admission were excluded, which is dif-
ficult to control in stroke registries. After external val-
idation, the current study might therefore be better
applicable when selection of patients in a randomised
trial is considered. Finally, this study includes patients
with either ischaemic stroke or intracerebral haemor-
rhage. The A2DS2 score was not developed in patients
with intracerebral haemorrhage, the ISAN score was
Table 3. Prediction chart for PASS pneumonia rule and PASS infection rule.
PASS pneumonia rule PASS infection rule
Characteristic Points Characteristic Points
Age Age
- 51–60 1 - 51–60 1
- 61–70 2 - 61–70 2
- 71–80 3 - 71–80 3
- >80 4 - >80 4
Male sex 2 Male sex 1
History of History of
- COPD 2 - COPD 2
- diabetes 1
Pre-stroke disability
- mRS 1–2 2
- mRS> 2 1
Intracerebral haemorrhage 1 Intracerebral haemorrhage 1
Stroke severity (NIHSS) Stroke severity (NIHSS)
- 6–10 2 - 6–10 2
- 11–20 4 - 11–20 4
- 21–30 6 - 21–30 6
Use of bladder catheter 6
Dysphagia 5 Dysphagia 4
Score Risk category Pneumonia % (n/N) Score Risk category Infection % (n/N)
0–5 Low 1 (7/1072) 0–5 Low 4 (47/1315)
6–10 Moderate 4 (34/855) 6–10 Moderate 11 (72/633)
11–15 High 17 (88/507) 11–16 High 31 (116/379)
16–22 Very high 29 (30/104) 17–24 Very high 54 (113/211)
PASS: preventive antibiotics in stroke study; COPD: chronic obstructive pulmonary disease; NIHSS: National Institutes of Health Stroke Scale score.
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shown to perform less well in patients with intracere-
bral haemorrhage and other scores were made for
either ischaemic or intracerebral haemorrhage.19 If
our results are confirmed in an independent popula-
tion, the PASS pneumonia rule and infection rule
could be applicable to patients with either ischaemic
stroke or intracerebral haemorrhage (Table 3).
This study has limitations. First, the PASS dataset
did not contain all characteristics reported in previous
studies as possible risk factors for infection or pneumo-
nia. For example, history of dementia, ‘being found
down at symptom onset’, location of stroke, ‘tongue
pressure movements’ or laboratory markers such as
monocytic HLA-DR, IL-1 or IL-6 were not prospec-
tively collected in the PASS. Also, CT- or MRI-
characteristics of an infarct or bleeding were not used
for the development of this model. Since the strongest
predictors for infection – as described in literature –
were included, it is unlikely that this strongly affected
the results and that these factors would otherwise have
been included in the model. Also, patients included in
PASS had a relatively mild stroke severity that
decreased infection and pneumonia rates. External val-
idation should be performed to assess the performance
of the model in stroke patients with higher stroke sever-
ity and infection rates. Next, the predictive value of the
use of a bladder catheter could be overestimated, since
it cannot be excluded that asymptomatic bacteriuria
was interpreted as bladder infection in patients with a
bladder catheter. Also, in standard stroke practice in
the Netherlands, the majority of patients will receive a
bladder catheter within the first 24 h when needed, but
we did not collect the exact date and time of placement
of the catheter. Finally, intracerebral haemorrhage was
selected as a predictor for both infections and pneumo-
nia, but this might be explained by increased length of
stay. Patients with intracerebral haemorrhage had a
longer length of stay than patients with ischaemic
stroke, and we used the length of admission as expo-
sure time for infections and pneumonia.
In conclusion, we present internally validated risk
scores for post-stroke infection and pneumonia. After
external validation, these scores can be used for selec-
tion of patients at high risk of infection and pneumonia
after stroke.
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